Clinical Report: Assessing Arabic-Language Websites on HPV and Cervical Cancer

Overview

The article describes the rationale for a multidimensional assessment of Arabic-language websites covering HPV and cervical cancer, noting that such resources had not previously undergone systematic evaluation across readability, engagement, usability, accessibility, and information quality. It situates this gap within substantial cervical cancer burden, low screening uptake, and reported knowledge gaps in Arab populations. The supplied material provides background and study rationale but no methods or results from the website assessment.

Background

Online health information seeking is widespread, including in the Arab Gulf region, where Internet use is nearly universal and a Saudi study found that 90.9% of 1,363 participants used online platforms to improve health awareness. Cervical cancer is the fourth most frequently occurring cancer in women worldwide, and persistent HPV infection accounts for nearly all cases; GLOBOCAN 2024 estimates 14,153 new cases and 7,702 deaths in the WHO Eastern Mediterranean Region during 2024. The source reports a pooled cervical cancer screening rate of 17.6% across Arab countries, as well as limited HPV and vaccination knowledge and low vaccine uptake in Gulf populations. Prior assessments of Arabic-language health websites have identified shortcomings in sourcing, authorship, and content quality, while the article states that Arabic websites on HPV and cervical cancer had not been comprehensively assessed across multiple quality dimensions.

Data Highlights

Key Findings

• The article identifies a gap in systematic, multidimensional assessment of Arabic-language websites providing information about HPV and cervical cancer.
• The proposed assessment dimensions include readability, user engagement, usability, accessibility, and information quality.
• The introduction reports that nearly all populations in Saudi Arabia, Bahrain, and the United Arab Emirates use the Internet, and cites a Saudi study in which 90.9% of 1,363 participants used online platforms to enhance health awareness.
• GLOBOCAN 2024 estimates cited in the article indicate approximately 14,153 new cervical cancer diagnoses and 7,702 deaths in the WHO Eastern Mediterranean Region during 2024.
• The source reports a pooled cervical cancer screening rate of 17.6% across Arab countries and HPV vaccine uptake of 10% in Gulf countries, alongside limited knowledge of HPV and vaccination.
• Earlier evaluations of Arabic-language websites on oral cancer and epilepsy are described as finding shortcomings in information sourcing, authorship, and overall content quality.

Clinical Implications

The source identifies accurate, evidence-based online information about HPV and cervical cancer as important in a setting where Internet use is widespread and screening and awareness gaps are reported. It does not provide results from the website assessment or specific clinical recommendations, so no conclusions about the quality of individual websites can be drawn from the supplied material.

Conclusion

The article establishes the need to evaluate Arabic-language HPV and cervical cancer websites across complementary dimensions of access, usability, engagement, readability, and information quality. The supplied text presents the rationale and relevant regional context but does not include the assessment findings.

Related Resources & Content

1. Article introduction, supplied source, year not provided — Assessing Arabic-Language Websites on HPV and Cervical Cancer Across the Arab World: Readability, User Engagement, Usability, Accessibility, and Information Quality
2. ASCO Publications, 2023 — Barriers to cervical cancer screening in a developing Middle Eastern country: A nationwide survey
3. ASCO Publications, 2023 — The perception of cervical cancer screening and prevention among Saudi women
4. ASCO Publications — Evaluating knowledge, attitudes, and practices toward breast cancer and breast cancer screening among females in Arab countries of the Middle East: A systematic literature review.
5. ASCO Publications — Barriers to cervical cancer screening in a developing Middle Eastern country: A nationwide survey.
6. HPV Vaccine Recommendations | HPV | CDC
7. Noninferiority of One HPV Vaccine Dose to Two Doses | New England Journal of Medicine
8. Federal Register / Vol. 91, No. 2 / Monday, January 5, 2026 / Notices
9. Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline - Perkins - 2026 - CA: A Cancer Journal for Clinicians - Wiley Online Library
10. DEN240045.Letter.Grant.FINAL
11. ASCCP Practice Advisory: Self Collection for Cervical Cancer Screening
12. Pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer: Final analysis results of the phase 3, randomized, double-blind ENGOT-cx11/GOG-3047/KEYNOTE-A18 study. | Journal of Clinical Oncology
13. Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial - PubMed
14. Cervical Cancer | New England Journal of Medicine